| Literature DB >> 16965788 |
Joe X Zhou1, Tim Tressel, Uwe Gottschalk, Felix Solamo, Andre Pastor, Shinta Dermawan, Tony Hong, Oscar Reif, Jeff Mora, Fred Hutchison, Michael Murphy.
Abstract
Process-scale antibody production requires polishing steps with extremely high product throughput and robust operation. In this communication, the Sartobind Q membrane adsorber for process-scale antibody production is evaluated as an alternative to Q column chromatography. Although the capacity seen with large-scale membrane adsorbers is competitive with column chromatography, the same throughput is not achieved with the current scale-down models. The operational issues currently found in membrane scale-down models, including backpressure, which significantly compromises the membrane's capacity, were examined. A new scale-down model was designed to mimic the liquid flow path found in the large-scale capsule, and a new process capacity equivalent at both small and large scale was successfully achieved. Results of a 4-model virus study with a redesigned Sartobind Q absorber scale-down model at the new process capacity are presented.Mesh:
Substances:
Year: 2006 PMID: 16965788 DOI: 10.1016/j.chroma.2006.08.064
Source DB: PubMed Journal: J Chromatogr A ISSN: 0021-9673 Impact factor: 4.759